Targeted Delivery of Anti-CTLA-4 Antibody Downregulates T Cell Function in Vitro and in Vivo
- 30 November 2001
- journal article
- Published by Elsevier BV in Clinical Immunology
- Vol. 101 (2), 136-145
- https://doi.org/10.1006/clim.2001.5119
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Mouse Inducible Costimulatory Molecule (ICOS) Expression Is Enhanced by CD28 Costimulation and Regulates Differentiation of CD4+ T CellsPublished by The American Association of Immunologists ,2000
- The role of T cells in autoimmune uveitisOcular Immunology and Inflammation, 2000
- Blockade of T Cell Activation Using a Surface-Linked Single-Chain Antibody to CTLA-4 (CD152)The Journal of Immunology, 2000
- The role of interleukin-12 and interferon-γ in GVHD and GVLCytokines, Cellular & Molecular Therapy, 2000
- CTLA-4 and T cell activationCurrent Opinion in Immunology, 1999
- The Complexities of T‐Cell Co‐stimulation: CD28 and BeyondImmunological Reviews, 1996
- The Role of B7‐1/B7‐2:CD28/CLTA‐4 Pathways in the Prevention of Anergy, Induction of Productive Immunity and Down‐Regulation of the Immune ResponseImmunological Reviews, 1996
- CTLA-4 ligation blocks CD28-dependent T cell activation.The Journal of Experimental Medicine, 1996
- Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4Science, 1995
- New perspectives of C1328-137-mediated T cell costimulationImmunity, 1995